KD3-IFN

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameKD3-IFN
Drug Alias Nameoncolytic adenovirus therapy expressing IFN-alpha (Introgen Therapeutics)KD3KD3-IFN
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunostimulantsInterferon alpha ligand
TargetsInterferon alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIntrogen Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntrogen Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A